STUDY GOALS AND OBJECTIVES
This study is intended to provide readers with an understanding of the global market for asthma and chronic obstructive pulmonary disease (COPD) prescription drugs. The study outlines the industry structure, competitive aspects, current developments, and future trends in the market, to assist in identifying areas of commercial interest and potential in the asthma and COPD indications.
The objectives of the study include the assessment of current market status, the analysis of marketed drugs, market revenues, company shares, unmet market needs, market challenges, and future trends. Future market revenues are forecast for the global market, major drug classes, individual disease indication, and largest geographical regions. The study also reviews the compounds currently being investigated in clinical studies for the treatment of asthma and COPD.
REASONS FOR DOING THE STUDY
Asthma and COPD are two diseases experiencing increasing prevalence globally due to a combination of factors, including a globally aging population and increasing pollution levels. COPD is one of the top five causes of disability and death in industrialized countries and the fourth-leading cause of death globally.
The market for asthma and COPD drugs had global revenues in 2010 that exceeded $34 billion annually. These drugs enjoy tremendous commercial success, as illustrated by the presence of six currently marketed multibillion-dollar drugs in this market. However, there is a perceived high level of unmet need in this market in terms of treatment options for asthma and COPD patients.
With the loss of patent protection on several major COPD and asthma drugs between 2010 and 2017, the cost for some treatments is expected to decrease as generic versions gain market share. Additionally, several new drugs are projected to enter the market through 2017, and they will continue to drive growth of revenues for asthma and COPD drugs.
More Respiratory/Pulmonary reports by BCC Research
Pharmaceuticals: Pulmonary Drug Delivery Systems: Technologies and Global Markets by BCC Research
Pharmaceuticals: Pulmonary Drug Delivery Systems: Technologies and Global Markets
The global market for pulmonary drug delivery technologies reached $32.4 billion in 2013 ...
See all reports like this >>
Pulmonary Drug Delivery Systems: Technologies and Global Markets by BCC Research
The global pulmonary drug delivery technologies market which was $19.6 billion in 2010 is expected to be around $22.5 billion by 2011. This global market ...
More Global Respiratory/Pulmonary reports
Lung Transplantation Global Clinical Trials Review, H2, 2014 by GlobalData
Lung Transplantation Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, “Lung Transplantation Global Clinical Trials Review, H2, 2014 provides data on the Lung Transplantation ...
Acute Lung Injury Global Clinical Trials Review, H2, 2014 by GlobalData
Acute Lung Injury Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, “Acute Lung Injury Global Clinical Trials Review, H2, 2014 provides data on the ...
A Competitive Analysis of the Global Asthma and COPD Therapeutics Market by Frost & Sullivan
A Competitive Analysis of the Global Asthma and COPD Therapeutics Market
Chronic obstructive pulmonary disorder (COPD) is the third leading cause of ...
See all reports like this >>
Global Influenza Market 2014-2018 by TechNavio - Infiniti Research Ltd.
Global Influenza Market 2014-2018About InfluenzaInfluenza is a contagious respiratory disease caused by influenza viruses. These viruses infect the nose, throat, and lungs causing mild to ...